SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
TWST

Twist Bioscience Corp (TWST)

NASDAQ: TWST · USD
Healthcare · Biotechnology
$103.32-$8.30 (-7.44%)
 
Market cap
$7.04B
Insider Score
Analyst consensus
Market Cap$7.04B+296.3%
Revenue (ttm)$459.43M
Net Income-$130.20M
EPS-$2.08
Shares Out68.18M
PE Ration/a
Forward PE1581.51
Dividendn/a
Ex-Dividend Daten/a
Volume3,378,941
Open$108.39
Previous Close$111.62
Day's Range$101.00 - $108.50
52-Week Range$25.67 - $219.71
Beta2.22
AnalystsBuy
Price Target$128.82(+24.68%)
Earnings DateFeb 1, 2027

About TWST

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; and Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, and other applications. It provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Address
681 Gateway Boulevard, South San Francisco, CA, 94080, United States
Market Cap
7.04 billion
Employees
1,080
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$7.23M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
5 Buy0 Hold1 SellAvg target $110.00 (+6.5%)

6 firms rating TWST in the last 3 months, one vote each. Issuer-paid research is not counted.

Next catalysts

1 Day
-7.44%
5 Days
-7.42%
1 Month
-23.73%
6 Months
+70.58%
1 Year
+296.32%

$TWST stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in TWST holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by TWST's directors and management

Net Shares Purchased by Insiders−70k−35k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

TWST Estimated quarterly lobbying spending

Source: U.S. Senate LDA

TWST Revenue by Segment or Geography

$459.43MTotal
NGS Applications$237.54M51.70%
DNA Synthesis and Protein Solutions$221.89M48.30%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-K)

U.S. Patents

New TWST patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to TWST from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in TWST

IWMiShares Russell 2000 ETF$256.65M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from TWST’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
83
News & Sentiment
20% of score
45

News check: Analyst downgrade offset by strong Q4 earnings with record revenue and positive guidance; valuation concerns temper gains.

Recent Insider Activity

Buys
0
Sells
17
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

-36.0 since Aug 21
0255075100Aug 21 — Insider Score 36.0Aug 22 — Insider Score 36.0Aug 23 — Insider Score 36.0Aug 24 — Insider Score 36.0Aug 25 — Insider Score 36.0Aug 26 — Insider Score 36.0Aug 27 — Insider Score 36.0Aug 28 — Insider Score 36.0Aug 29 — Insider Score 36.0Aug 30 — Insider Score 36.0Aug 31 — Insider Score 36.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 32.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 21Sep 12Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

ARKGARK Genomic Revolution ETF7.65%
GNOMGlobal X - Genomics & Biotechnology ETF5.55%
IDNAiShares Genomics Immunology and Healthcare ETF4.94%
HLTHTema Healthcare AI ETF4.47%
RKNGETF Series Solutions - Defiance Retail Kings ETF3.51%
EDOCGlobal X Telemedicine & Digital Health ETF3.20%
HELXFranklin Genomic Advancements ETF3.18%
WDNAWisdomTree BioRevolution Fund3.00%
ARKKARK Innovation ETF2.94%
FRTYAlger Mid Cap 40 ETF2.76%
PTHInvesco Dorsey Wright Healthcare Momentum ETF2.41%
HAPSHarbor Human Capital Factor US Small Cap ETF2.02%

Weight is the stock’s share of each fund’s holdings.